ZNF462 rs16912205: Understanding Weiss-Kruszka Syndrome Links
The ZNF462 gene is associated with Weiss-Kruszka syndrome, a rare neurodevelopmental disorder characterized by developmental delays and specific craniofacial features. Variants in this gene, including those identified in clinical research, are studied for their role in disrupting normal embryonic development.
What each genotype means
Typical skin barrier and hydration
You carry two copies of the C allele at rs16912205 in the ZNF462 region. Genome-wide association studies suggest this genotype is associated with baseline facial skin barrier hydration and standard intrinsic wrinkle formation patterns. Because this locus was primarily identified in East Asian cohort research, its practical significance across different ancestries and environments remains modest and non-diagnostic.
Carried by approximately 70% to 75% of East Asian individuals and common across diverse global populations.
Intermediate skin hydration tendency
You carry one copy of the T minor allele at rs16912205. Published association data indicate a possible subtle shift in epidermal hydration balance and facial skin aging pathways compared to the baseline genotype. The clinical evidence for this variant is limited and observational, reflecting statistical trends rather than deterministic biological outcomes.
Carried by roughly 25% of individuals of East Asian ancestry and occurs at varying frequencies globally.
Altered skin hydration profile
You carry two copies of the T allele at rs16912205 near ZNF462. Research links this genotype to statistical differences in facial stratum corneum hydration and extrinsic wrinkle sensitivity. Evidence for this association remains limited and population-specific, meaning environmental factors such as UV exposure and general skincare have a far greater impact on skin barrier health.
Carried by approximately 2% to 3% of East Asian individuals and generally infrequent worldwide.
What is the ZNF462 Gene?
The ZNF462 gene provides instructions for creating a zinc finger protein, which is a type of protein that typically binds to DNA to regulate gene activity. Located on chromosome 9, this gene is thought to play a critical role in embryonic morphogenesis, the process by which an embryo develops its shape and structure. Because it acts as a transcription factor, ZNF462 helps control the expression of other genes necessary for the development of the brain and facial structures. Research suggests that when this gene does not function correctly, it can lead to a condition known as Weiss-Kruszka syndrome. Scientists are still working to fully understand the specific molecular pathways that ZNF462 influences, but its importance in early human development is well-documented in clinical literature.
Research and Clinical Associations
Weiss-Kruszka syndrome is a rare, autosomal dominant neurodevelopmental disorder. Clinical research has linked pathogenic variants in ZNF462 to a range of symptoms, including global developmental delay, intellectual disability, and characteristic facial features such as ptosis (drooping eyelids) and arched eyebrows. Some individuals also exhibit structural brain differences, such as dysgenesis of the corpus callosum, and other congenital anomalies like heart defects or limb differences. It is important to note that the syndrome shows significant phenotypic heterogeneity, meaning that the severity and specific combination of symptoms can vary widely even among individuals with the same genetic variant. Because the condition is rare, with fewer than 100 cases reported in medical literature, our understanding of the full spectrum of symptoms continues to evolve as more research is conducted.
Understanding Genetic Variants
In genetics, a variant like rs16912205 represents a specific position in the DNA sequence where individuals may differ. When discussing ZNF462, researchers focus on 'loss-of-function' variants, which prevent the gene from producing a working protein or reduce its activity significantly. Most cases of Weiss-Kruszka syndrome are caused by de novo variants, meaning they occur spontaneously in the individual and are not inherited from either parent. However, in a small percentage of cases, the variant can be passed down from an affected parent. Because this is a rare condition, genetic testing is typically performed in a clinical setting when a healthcare provider suspects a neurodevelopmental disorder based on a patient's physical and developmental presentation. Genetic results should always be interpreted by a qualified medical geneticist or counselor who can provide context based on an individual's specific health history.
What You Can Do With This Information
If you or a family member have received a report mentioning a ZNF462 variant, it is essential to discuss these findings with a medical professional. This information is intended for educational purposes and does not constitute a medical diagnosis or a prediction of future health outcomes. Because Weiss-Kruszka syndrome is complex and rare, clinical management is highly individualized, focusing on supportive care for developmental delays and monitoring for specific physical health needs. You cannot use this information to self-diagnose or make decisions about medical treatment. If you are concerned about genetic risks, consider requesting a referral to a clinical geneticist. They can help explain the significance of specific variants, discuss the possibility of inheritance, and provide guidance on appropriate clinical follow-up or testing for other family members if necessary.
How common is this variant?
The ZNF462 variants associated with Weiss-Kruszka syndrome are considered rare in the general population. Most reported cases are de novo, meaning they are not common inherited traits found in the general gene pool.
Frequently asked questions
What is Weiss-Kruszka syndrome?
Weiss-Kruszka syndrome is a rare neurodevelopmental disorder caused by loss-of-function variants in the ZNF462 gene. It is characterized by developmental delays, intellectual disability, and specific facial features.
Is ZNF462-related syndrome inherited?
Most cases of Weiss-Kruszka syndrome are de novo, meaning they occur for the first time in an individual. However, it is inherited in an autosomal dominant manner, meaning an affected parent has a 50% chance of passing the variant to their child.
How is this condition diagnosed?
Diagnosis is typically established through clinical evaluation by a geneticist and confirmed via molecular genetic testing, such as whole-exome sequencing, to identify a pathogenic variant in ZNF462.
Are there treatments for ZNF462-related disorders?
There is no cure for the underlying genetic cause, but treatment focuses on managing symptoms. This often involves early intervention services, physical or speech therapy, and monitoring by specialists for specific health concerns.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16912205?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29